You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 5,914,267


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,914,267
Title: Pre-mRNA processing enhancer and method for intron-independent gene expression
Abstract:A chimeric RNA molecule comprising at least one pre-mRNA processing element is disclosed. A gene construct comprising a DNA sequence encoding at least one pre-mRNA processing enhancer is also disclosed. A method of enhancing cytoplasmic RNA accumulation is disclosed. This method comprises the step of inserting a DNA sequence encoding the RNA into the vector described and expressing the DNA sequence.
Inventor(s): Mertz; Janet E. (Madison, WI), Liu; Xuedong (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation (Madison, WI)
Application Number:08/887,434
Patent Claims:1. A chimeric RNA molecule comprising a 5' untranslated region, a 3' untranslated region, and a translatable intronless version of an intron-dependent transcript, wherein the 3' untranslated region of the RNA molecule further comprises at least one eukaryotic pre-mRNA processing enhancer not natively connected to the intronless version of an intron-dependent transcript.

2. The chimeric RNA molecule of claim 1, wherein the pre-mRNA processing enhancer enhances cytoplasmic accumulation of an intronless version of an intron-dependent transcript comprising said pre-mRNA processing enhancer in the 5' or 3' untranslated region of a chimeric RNA molecule comprising a 5' untranslated region, a 3' untranslated region, and an intronless version of an intron-dependent transcript.

3. The chimeric RNA molecule of claim 2, wherein the pre-mRNA processing enhancer has a sequence of no greater than 300 nucleotides and enhances the cytoplasmic accumulation of the intronless version of the intron-dependent transcript by at least two-fold with respect to accumulation in the absence of the enhancer.

4. The chimeric RNA molecule of claim 2, wherein the cytoplasmic accumulation of the intronless version of the intron-dependent transcript is enhanced by at least five-fold with respect to accumulation in the absence of the enhancer.

5. The chimeric RNA molecule of claim 2, wherein the cytoplasmic accumulation of the intronless version of the intron-dependent transcript is enhanced by at least 20-fold with respect to accumulation in the absence of the enhancer.

6. The chimeric RNA molecule of claim 2, wherein the pre-mRNA processing enhancer sequences is located at least 119 bases from the transcript cleavage site of the translatable intronless version of an intron-dependent transcript.

7. A chimeric RNA molecule comprising a 5' untranslated region, a 3' untranslated region, and a protein coding sequence, wherein the 3' untranslated region of the RNA molecule further comprises at least one eukaryotic pre-mRNA processing enhancer not natively connected to the protein coding sequence.

8. A genetic construct comprising a DNA sequence encoding at least one eukaryotic pre-mRNA processing enhancer, a promoter, and an intronless intron-dependent protein coding sequence, wherein the promoter is operably connected to the protein coding sequence, and wherein the enhancer is not natively connected to the protein coding sequence and is located 3' from the promoter and the protein coding sequence.

Details for Patent 5,914,267

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2015-05-22
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2015-05-22
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2015-05-22
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.